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 Background: Lung transplant recipients may suffer from airway stenosis (AS). The aim of this study was to assess whether 
pulmonary function (as measured by spirometry and a 6-minute walk test [6MWT]) in patients with AS treat-
ed consistently with bronchoscopic interventions (BIs) was comparable to that in their AS-free counterparts at 
the 1-year follow-up visit.
 Material/Methods: Fifty patients who underwent primary double-lung transplantation between January 2015 and March 2019 at 
a single center (23 who received BIs and 27 who did not) were enrolled in this retrospective study. Graft func-
tion was assessed with spirometry, based on forced expiratory volume (FEV1) and forced vital capacity (FVC), 
both measured in liters (L) and percentages (%), and the Tiffeneau-Pinelli index (FEV1/FVC), and a 6MWT and 
parameters such as oxygen saturation measured before and after the test.
 Results: Patients in need of BIs had significantly lower FEV1% compared with individuals who did not receive BIs during 
their first post-transplant year. Airway obstruction was present in 22% of patients who did not receive BIs and 
65.23% of those who did receive the interventions. There were statistically significant, strong, negative corre-
lations pertaining to the number of balloon BIs and 1-year FEV1% (rs=0.67) as well as the number of balloon 
BIs and 1-year FEV1/FVC (rs=0.72). A statistically significant, strong, negative correlation (rs=0.75) was found 
between the number of balloon bronchoplasty treatments and oxygen saturation after the 6WMT.
 Conclusions: Despite receiving BIs, patients who experience bronchial stenosis may not obtain the expected ventilatory 
improvement at their 1-year follow-up visit. Their AS may recur or persist despite use of various procedures. 
Further study in that regard is required.
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Background
Lung transplantation is the ultimate treatment for patients with 
end-stage lung disease. The survival rate after the procedure is 
good, with 50% of patients living 7.8 years after double-lung 
transplantation [1]. The procedure also is associated with im-
proved pulmonary function and exercise capacity [2]. However, 
a significant number of double-lung recipients do not achieve 
80% of predicted forced vital capacity (FVC) during their first 
post-transplant year [3]. In some cases, the finding can be ex-
plained by a ventilatory defect caused by airway complications 
located in bronchial anastomoses [4,5]. Prevalence is reported 
to range from 10% to 33%, but most experts agree that such 
complications occur in approximately 15% of lung transplant 
recipients [4,6,7]. Many factors, such as graft ischemic time 
and pretransplant microbiological colonization, can contribute 
to development of airway stenosis (AS) [5,6]. During the post-
transplant period, patients may experience airway complica-
tions such as bronchial stenosis, exophytic necrotic tissue, and 
bronchomalacia [5]. Bronchoscopic interventions (BIs) available 
include balloon bronchoplasty, cryotherapy, argon plasma co-
agulation, and laser therapy; in some cases, airway stenting is 
a last resort [4]. Even though AS does not influence survival in 
graft recipients, it can cause persistent airflow limitation de-
spite frequent use of BIs [8]. Questions remain about whether 
BIs used to treat AS can improve a patient’s ventilation perma-
nently and whether these measures can improve spirometry 
results such that they are comparable to those in lung recip-
ients who do not have AS. The aim of the present study was 
to assess whether pulmonary function (as measured by spi-
rometry and a 6-minute walk test [6MWT]) in patients with AS 
treated consistently with BIs was comparable to that in their 
AS-free counterparts at the 1-year follow-up visit.
Material and Methods
This retrospective study included 50 patients who under-
went primary double-lung transplantation between January 
2015 and March 2019 in our facility and had reached at least 
1-year follow-up. The inclusion criteria were transplantation 
at age 15 years or older and absence during the study peri-
od of conditions or related procedures that would influence 
lung function, such as acid reflux, fundoplication surgery, and 
musculoskeletal disorders. Exclusion criteria were single-lung 
transplantation, retransplantation during the follow-up period, 
and existence of conditions such as a significant aortic aneu-
rysm that would prevent performance of pulmonary function 
testing during the study follow-up. Detailed characteristics of 
the patients are listed in Table 1.
In the present study, graft function was assessed with spirome-
try and the Tiffeneau-Pinelli index and measurement of oxygen 
saturation before and after a 6MWT. Spirometry consisted of 
measurement of forced expiratory volume (FEV1) and forced 
vital capacity (FVC), both in liters (L) and percentages (%). The 
Tiffeneau-Pinelli index is FEV1/FVC. All of the tests were per-
formed on the first day of patient admission for the 1-year 
follow-up visit after lung transplantation. Any BIs were per-
formed after the testing because the aim of the study was to 
assess lung function 1 year after lung transplantation. Airway 
obstruction was defined as FEV1/FVC <70%. Results obtained 
from 6MWTs that were terminated for non-pulmonary rea-
sons, such as a significant increase in blood pressure or ac-
tive musculoskeletal injury of the lower limbs, were exclud-
ed from the study.
The primary endpoint of the study was to assess whether 
there was a difference in pulmonary function in patients who 
required BIs. The study group was divided into 2 groups: pa-
tients who did not undergo BI and those who had ³1 BI during 
the first year after transplantation. BI was performed mainly by 
means of balloon dilation, but cryotherapy, laser therapy, and 
argon plasma coagulation also were used. Hypertrophic steno-
ses of the bronchial anastomoses in the course of complicated 
healing were the main reason for the aforementioned treat-
ment. None of the patients experienced bronchial dehiscence.
Statistical analysis was carried out using TIBCO Statistica 
13.30 software, including assessment of basic statistics and 
Shapiro-Wilk tests. A t test and Mann-Whitney U test were 
performed as appropriate. Correlation analyses based on the 
nonparametric Spearman rank correlation coefficient (rs) were 
performed to analyze the relationship between variables. The 
classic threshold for significance was a=0.05.
Results
Twenty-three of 50 patients assessed during 1-year follow-
up required ³1 BI that involved, at a minimum, balloon bron-
choplasty. The mean number of BIs in the study population 
was 6.78±5.89 (minimum 1, maximum 19). The primary end-
point of the study was to assess whether patients who un-
derwent ³1 BI during the first year had worse results on pul-
monary function tests performed during the routine check-up 
visit 1 year after lung transplantation. Spirometry parameters 
such as FEV1, FVC, and the Tiffeneau-Pinelli index were evalu-
ated. Detailed results of testing are shown in Table 2. Patients 
who underwent BIs because of significant AS had significant-
ly lower FEV1% compared with those without BI during their 
first post-transplant year. Similar results were demonstrated 
for mean FVC%. Airway obstruction was present in 22% of pa-
tients without BI as well as 65.23% of those with a history of 
BI. Median values for the Tiffeneau-Pinelli index differed sig-
nificantly in patients, depending on their BI status, as shown 
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in Table 2. During every follow-up visit, our patients perform 
the 6MWT. There was no statistically significant difference be-
tween the groups in distance achieved on this test. However, 
oxygen saturation measured before the test was notably low-
er in the patients who had undergone ³1 BI during their first 
post-transplant year. A comparison of the 6MWT results is 
shown in Table 2.
Further investigations were performed to establish whether 
there was a connection between BI and results of pulmonary 
function tests. Our analyses were based on a Spearman rank 
correlation coefficient, as shown in Table 3. The impact on 
spirometry parameters of the number of BIs involving at least 
balloon B was established. There were statistically significant, 
strong, negative correlations between the number of balloon 
BIs and 1-year FEV1% (rs=0.67) and the number of balloon BIs 
Studied group (n=50) Patients without BI (n=27) Patients with BI (n=23) p Value
Age at transplantation [ME±IQR]  40.00±8.00  39.00±5.00 0.529
BMI at transplant [M±SD]  23.34±2.56  24.17±3.67 0.365
RBC at qualification [ME±IQR]  4.89000±0.48  4.88±0.63 0.683
HGB at qualification [ME±IQR]  11.7±5.40  10.30±3.65 0.592
FEV1 [%] at qualification [ME±IQR]  23.40±11.00  27.00±14.00 0.311
FVC [%] at qualification [M±SD]  47.98±23.55  45.54±15.14 0.732
RBC 1 year [M±SD]  3.92±0.46  3.87±0.57 0.702
HGB 1 year  [M±SD]  7.25±0.78  7.39±1.00 0.594
GFR 1 year [ME±IQR]  67.19±43.69  57.38±26.23 0.741
Gender as percentage of male participants 51.85% 47.82%  
Underlying disease [%]   
 CF 48.16% 43.48%  
 IPAH 14.81% 8.70%  
 ILD 14.81% 17.39%  
 COPD 22.22% 26.09%  
 Other 0.00% 4.35%  
Table 1. General characteristics of patients included in the study.
6MWT – 6-minute walk test; BI – bronchoscopic intervention; BMI – body mass index; CF – cystic fibrosis; COPD – chronic obstructive 
pulmonary disease; FEV1 – forced expiratory volume in 1 second; FEV1/FVC – Tiffeneau-Pinelli index; FVC – forced vital capacity; 
GFR – glomerular filtration rate; HGB – hemoglobin; IPAH – idiopathic pulmonary arterial hypertension; ILD – interstitial lung disease; 
IQR – interquartile range; M – mean; Me – median; post-sat – oxygen saturation at the end of 6-minute walk test; pre-sat – oxygen 
saturation measured at the beginning of 6-minute walk test; RBC - red blood cells; SD – standard deviation.
 Patients without BI (n=27) Patients with BI (n=23) p-Value
FEV1% [M±SD]  81.3333±26.8958  54.3913±20.88875 0.000
FEV1/FVC [Me±IQR]  78.00000±18.00000  62.00000±32.00000 0.004*
FVC% [M±SD]  87.8519±20.4426  75.2174±19.28956 0.030
6MWT distance [M±SD]  509.2370±100.7069  522.0435±79.74776 0.625
6MWT pre-sat [%][M±SD]  98.3333±1.4676  97.5652±1.16096 0.048
6MWT post-sat [%] [M±SD]  95.7778±2.5770  94.5652±2.72740 0.113
Table 2. Pulmonary function tests at 1-year follow-up in patients with or without bronchoscopic interventions.
* p-Value was assessed by U-Mann Whitney test. All other p-values are the result of t-student tests; 6MWT – 6-minute walk test; 
BI – bronchoscopic intervention; FEV1 – forced expiratory volume in 1 second; FEV1/FVC – Tiffeneau-Pinelli index; FVC – forced 
vital capacity; IQR – interquartile range; M – mean; Me – median; post-sat – oxygen saturation at the end of 6-minute walk test; 
pre-sat – oxygen saturation measured at the beginning of 6-minute walk test; SD – standard deviation.
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and 1-year FEV1/FVC (rs=0.72). Balloon BI did not have an ef-
fect on 1-year FVC%.
No correlation was found between the number of balloon BIs 
and distance on the 6MWT. However, the aforementioned anal-
yses showed that there was a statistically significant, moder-
ate, negative correlation (rs=0.46) between balloon BI and ox-
ygen saturation measured at the end of the 6MWT (6MWT 
post-sat). Spirometry parameters such as FEV1% and FEV1/FVC 
also had a statistically significant, strong, positive correlation 
with 6MWT post-sat.
The data gathered allowed the researchers to assess whether 
balloon BI would also influence spirometry results at 2-year 
follow-up; the differences in those outcomes were not statis-
tically significant. Nevertheless, we found that the more bal-
loon BIs patients undergo, the worse their 6MWT post-sat may 
be at the 2-year check-up visit (statistically significant, strong, 
negative correlation of rs=0.75).
Our clinical observations led us to statistically test whether 
there was a chance of improvement in the pulmonary function 
tests over time. We found statistically significant, very strong, 
positive correlations between FEV1% obtained at 1 and 2 years 
(rs=0.92). This means that patients who underwent BI during 
the first year will most likely have similar FEV1% in the first 
and second years after transplant. We made the same obser-
vation in regard to FEV1/FVC (rs=0.92).
Discussion
Spirometry is considered to be the cornerstone of graft func-
tion monitoring [3]. Our study revealed that in patients who 
required ≥1 BI during their first post-transplant year, spirom-
etry parameters were statistically significantly lower than in 
patients who did not need such bronchoscopic treatment. A 
similar finding was reported by Mazzetta et al. [8], who found 
that patients with central AS so severe it required BI had low-
er FEV1 (L) and FEV1/FVC at 18-month follow-up (81±13% ver-
sus 61±14%, P<0.001).
Our study assessed patients during the first visit after reach-
ing 1-year follow-up. We also reported a statistically signifi-
cant difference between our study groups in FEV1 (%) between 
our study groups (81±27% versus 54±21%, P<0.001) and 
FEV1/FVC (78±18% versus 62±32%, P=0.004). Mazzetta et al. 
also showed that CAS does not affect the survival of lung trans-
plant recipients [8]. That is supported by a paper published by 
Shofer et al. [7]. In contrast, Mohanka et al. found that fail-
ure to achieve FVC ³80% was an independent risk factor for 
3-year mortality [3].
In our study, patients who required BI reported significantly 
lower FVC% than their BI-free counterparts (75±19% versus 
88±20%, P=0.03). Thirty percent of BI-free patients did not 
achieve FVC ³80%, compared with 52% of those who required 
BI. Our study also indicates that the more balloon broncho-
plasty procedures patients require during the first post-trans-
plant year, the worse spirometry parameters they may present 
at 1- and 2-year follow-up because the aforementioned statis-
tical analyses showed a strong, negative correlation between 
No.  Studied pair of variables rs S p
1 Number of BBI & 1-year FEV1 [%] –0.67 3386.81 <0.001
2 Number of BBI & 1-year FEV1/FVC –0.72 3487.04 <0.001
3 Number of BBI & 1-year 6MWTpost-sat [%] –0.46 2963.04 0.026
4 Number of BBI & 2-year FEV1 [%] –0.41 169.21 0.273
5 Number of BBI & 2-year FEV1/FVC –0.49 179.25 0.177
6 Number of BBI & 2-year 6MWT post-sat [%] –0.75 210.13 0.02
7 1-year FEV1 [%] & 2-year FEV1 [%] 0.92 10.0 0.001
8 1-year FEV1/FVC & 2-year FEV1/FVC 0.92 10.0 0.001
9 1-year FEV1 [%] & 1-year 6MWT post-sat [%] 0.52 977.7 0.012
10 1-year FEV1/FVC & 1-year 6MWTpost-sat [%] 0.65 708.06 0.001
Table 3. Correlation coefficients with corresponding Spearman’s rank (rs), statistics (S), and P values.
6MWT – 6-minute walk test; BBI – bronchoscopic interventions involving at least balloon bronchoplasty performed during the first 
year of follow-up after double lung transplantation; FEV1 – forced expiratory volume in 1 second; FEV1/FVC – Tiffeneau-Pinelli index; 
FVC – forced vital capacity; post-sat – oxygen saturation at the end of 6-minute walk test; pre-sat – oxygen saturation measured at the 
beginning of 6-minute walk test.
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BI and those parameters. As described by Sinha, even though 
balloon bronchoplasty alone provides intermediate improve-
ment, its effects are not long-lasting. In some cases, AS dila-
tation may be needed every 2 to 4 weeks [9]. It seems that BI 
other than stenting is only a palliative measure for maintain-
ing airway patency. As reported by Shofer et al., only 37% of 
patients will have resolution of bronchial complications with 
bronchoplasty alone, and, ultimately, more than 50% of those 
individuals will require airway stenting [7]. Improvement in 
ventilation as assessed by spirometry has been reported af-
ter stent placement [10]. However, this therapeutic method is 
not free from adverse effects. Stent placement reportedly is 
associated with mucus plugging, ingrowth of granulation tis-
sue, and microbiological colonization and harm when a stent 
migrates [9]. That is why AS stenting should be a last-resort 
treatment [11].
To the best of our knowledge, no reports exist about the influ-
ence of AS and BI on exercise capacity assessed by the 6MWT. 
It is important to note that the worse a patient’s FEV1% at 
1-year follow-up, the worse his or her oxygen saturation after 
the 6MWT is likely to be. This finding may have clinical impli-
cations because it indicates that unsatisfactory ventilation is 
connected with oxygen deficit during exercise. The distance on 
the 6MWT did not differ between our study groups.
Because every bronchoscopic technique has adverse effects, 
such procedures should only be performed in carefully select-
ed patients [9].
Conclusions
BIs without stenting may result in temporary improvement in 
individuals who have undergone primary double-lung trans-
plantation. Despite use of these therapies, however, patients 
who experience bronchial stenosis may not obtain expected 
long-term improvement in ventilatory parameters at the 1-year 
follow-up visit. It is notable that CAS can recur or persist even 
when various BIs are used. The present study also suggests 
that unsatisfactory ventilation may be connected with oxygen 
deficit during exercise. The number of balloon bronchoplasty 
procedures a patient has undergone may be associated with 
worse results obtained during spirometry and on the 6MWT. 
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